1. Catalog
  2. Long-Acting Injectable Buprenorphine
Image For Activity Cover
Long-Acting Injectable Buprenorphine
Faculty
Dr. Sarah Spencer

Dr. Spencer is a family practitioner and addiction medicine specialist who has been providing treatment of substance use disorders in rural Alaska for over a decade. She is the volunteer medical director and founding member of Megan’s Place, the first rural syringe access program in Alaska. She also partners with the State of Alaska’s Project HOPE and she currently works at Ninilchik Community Clinic as an Addiction Medicine Physician. 
Learning Objectives
  1. Review the pharmacokinetics of Long-acting Injectable Buprenorphine (LIAB).
  2. Explore LIAB regulatory and logistical issues.
  3. Compare available weekly and monthly formulations.
  4. Develop appropriate LIAB initiation strategies.
  5. Troubleshoot common problems in early treatment .

Summary
Availability: On-Demand
Expires on Mar 05, 2027
Cost: FREE
Credit Offered:
1 Attendance Credit
Create Account
Recommended
 
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.


Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

  
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email PCSS-MOUD.

ORN
opioidresponsenetwork.org
Powered By